Sanofi Teams Up With SK Chemicals to Develop Pneumococcal Vaccine
March 19 2014 - 2:15AM
Dow Jones News
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Wednesday
said it has teamed up with South Korea's SK Chemicals Co.
(006120.SE) to develop a pneumococcal vaccine.
Sanofi will make an up-front payment of $23 million to SK
Chemicals. Both companies will develop the vaccine together, with
SK Chemicals producing it in a factory in South Korea.
The market for vaccines against diseases caused by streptococcus
pneumoniae, such as pneumonia, meningitis and febrile bacteraemia,
is worth $4 billion, Sanofi said in a statement.
Write to Inti Landauro at inti.landauro@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2024 to May 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From May 2023 to May 2024